Publikationen von F. Holsboer

Binder, E.; Mehta, D.; Ressler, K.; Holsboer, F.: Posttraumatic Stress Disorder Subtypes Invalid Reply. Archives of General Psychiatry 68 (9), S. 978 - 980 (2011)

Domschke, K.; Reif, A.; Weber, H.; Richter, J.; Hohoff, C.; Ohrmann, P.; Pedersen, A.; Bauer, J.; Suslow, T.; Kugel, H. et al.; Heindel, W.; Baumann, C.; Klauke, B.; Jacob, C.; Maier, W.; Fritze, J.; Bandelow, B.; Krakowitzky, P.; Rothermundt, M.; Erhardt, A.; Binder, E. B.; Holsboer, F.; Gerlach, A. L.; Kircher, T.; Lang, T.; Alpers, G. W.; Ströhle, A.; Fehm, L.; Gloster, A. T.; Wittchen, H. U.; Arolt, V.; Pauli, P.; Hamm, A.; Deckert, J.: Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Molecular Psychiatry 16 (9), S. 938 - 948 (2011)

Gassen, N. C.; Han, Y.; Wochnik, G.; Holsboer, F.; Rein, T.: Functional impact of FKBP51 on cellular pathways. Pharmacopsychiatry 44 (6), S. 290 - 290 (2011)

Herrmann, L.; Golub, Y.; Henes, K.; Ionescu, I.; Büll, D.; Holsboer, F.; Wotjak, C. W.; Schmidt, U.: Decreased expression of synaptic proteins in a mouse model of posttraumatic stress disorder. Pharmacopsychiatry 44 (6), S. 295 - 295 (2011)

Hoehn, D.; Czisch, M.; Spoormaker, V. I.; Schröter, M.; Goya-Maldonado, R.; Holsboer, F.; Sämann, P. G.: Resting state network alterations in major Depression. Pharmacopsychiatry 44 (6), S. 296 - 296 (2011)

Hoehne, N.; Rief, W.; Brückl, T.; Heck, A.; Pfister, H.; Lucae, S.; Uhr, M.; Holsboer, F.; Ising, M.: Stress coping strategies and HPA axis regulation predict relapse risk in remitted depression. European Neuropsychopharmacology 21 (Suppl. 3), S. S355 - S355 (2011)

Kiem, S. A.; Andrade, K. C.; Hoehn, D.; Goya-Maldonado, R.; Spoormaker, V. I.; Holsboer, F.; Czisch, M.; Sämann, P. G.: Combined fMRI/EEG to map non-genomic effects of exogeneous cortisol. Pharmacopsychiatry 44 (6), S. 297 - 297 (2011)

Lerche, K.; Willem, M.; Kleinknecht, K.; Romberg, C.; Konietzko, U.; Nitsch, R. M.; Holsboer, F.; Wurst, W.; Wotjak, C. T.; Deussing, J. M.: Dissecting the role of Corticotropin-releasing hormone receptor type 1 in Alzheimer's Disease. Pharmacopsychiatry 44 (6), S. 299 - 299 (2011)

Lucae, S.; Czamara, D.; Uhr, M.; Ising, M.; Holsboer, F.; Müller-Myhsok, B.: The non-synonymous P2RX7 SNP rs2230912 is associated with affective disorders: Results from an association study in major depression and from a meta-analysis. Pharmacopsychiatry 44 (6), S. 300 - 300 (2011)

Mehta, D.; Gonik, M.; Klengel, T.; Rex-Haffner, M.; Menke, A.; Rubel, J.; Mercer, K. B.; Pütz, B.; Bradley, B.; Holsboer, F. et al.; Ressler, K. J.; Müller-Myhsok, B.; Binder, E. B.: Using Polymorphisms in FKBP5 to Define Biologically Distinct Subtypes of Posttraumatic Stress Disorder Evidence From Endocrine and Gene Expression Studies. Archives of General Psychiatry 68 (9), S. 901 - 910 (2011)

Menke, A.; Eichelkraut, A.; Preis, L.; Klengel, T.; Rex-Haffner, M.; Uhr, M.; Holsboer, F.; Binder, E. B.: Gender related differential response to dexamethasone in endocrine and immune measures in depressed patients and healthy controls. Pharmacopsychiatry 44 (6), S. 300 - 300 (2011)

Menke, A.; Klengel, T.; Eichelkraut, A.; Preis, L.; Rex-Haffner, M.; Uhr, M.; Holsboer, F.; Binder, E. B.: Glucocorticoid induced FKBP5-gene expression in depressed patients and healthy controls. European Neuropsychopharmacology 21 (Suppl. 3), S. S248 - S249 (2011)

Moellmann, K. M.; Wurst, W.; Holsboer, F.; Deussing, J. M.: Towards brain-specific functions of histone deacetylases (HDACs) using genetic mouse models. Pharmacopsychiatry 44 (6), S. 301 - 301 (2011)

Nothdurfter, C.; Tanasic, S.; Di Benedetto, B.; Uhr, M.; Kessler, J.; Wagner, E. M.; Gilling, K.; Parsons, C.; Rein, T.; Holsboer, F. et al.; Rupprecht, R.; Rammes, G.: Impact of lipid raft integrity on GABAA receptor function and its modulation by benzodiazepines. Pharmacopsychiatry 44 (6), S. 302 - 302 (2011)

Pawlowski, M.; Dresler, M.; Holsboer, F.; Steiger, A.: Cordance as a biomarker in sleep-EEG for depression: responders versus non-responders: a naturalistic study after antidepressant medication. European Neuropsychopharmacology 21 (Suppl. 3), S. S360 - S361 (2011)

Sämann, P. G.; Hoehn, D.; Schröter, M.; Goya, R.; Spoormaker, V. I.; Holsboer, V.; Czisch, M.: Atlas parcellation and voxel based whole brain functional connectivity analysis applied to major depression: group results and biomarker potential. Pharmacopsychiatry 44 (6), S. 305 - 305 (2011)

Sämann, P. G.; Wehrle, R.; Hoehn, D.; Spoormaker, V. I.; Peters, H.; Tully, C.; Holsboer, F.; Czisch, M.: Development of the Brain's Default Mode Network from Wakefulness to Slow Wave Sleep. Cerebral Cortex 21 (9), S. 2082 - 2093 (2011)

Schosser, A.; Gaysina, D.; Cohen-Woods, S.; Domenici, E.; Perry, J.; Tozzi, F.; Korszun, A.; Gunasinghe, C.; Gray, J.; Jones, L. et al.; Binder, E. B.; Holsboer, F.; Craddock, N.; Owen, M. J.; Craig, I. W.; Farmer, A. E.; Muglia, P.; McGuffin, P.: A Follow-Up Case-Control Association Study of Tractable (Druggable) Genes in Recurrent Major Depression. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 156B (6), S. 640 - 650 (2011)

Stepan, J.; Dine, J.; Wolff, G. v.; Zieglgänsberger, W.; Holsboer, F.; Eder, M.: High-speed voltage-sensitive dye imaging of neuronal activity propagation through limbic brain networks in vitro. Pharmacopsychiatry 44 (6), S. 308 - 308 (2011)

Szesny, N.; Brückl, T.; Pfister, H.; Hennings, J. M.; Klengel, T.; Menke, A.; Uhr, M.; Lucae, S.; Holsboer, F.; Ising, M. et al.; Zihl, J.: Effectiveness of a standardized cognitive training in depression and the interaction with HPA-axis regulation. Pharmacopsychiatry 44 (6), S. 308 - 308 (2011)